Therapix Biosciences Ltd.
TRPX
TRPX was delisted on the 1st of July, 2020.
5 hedge funds and large institutions have $77K invested in Therapix Biosciences Ltd. in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
62% less capital invested
Capital invested by funds: $202K → $77K (-$125K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$21.9K |
| 2 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$407 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$77K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
-$58K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
| 4 |
Morgan Stanley
New York
|
-$711 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $54K | -$711 | -133 | -1% |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| $22K | +$21.9K | +4,100 | New |
|
|
PA
3
Parallel Advisors
San Francisco,
California
| $1K | – | – | – |
|
|
4
Jane Street
New York
| – | -$77K | -12,914 | Closed |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| – | -$58K | -10,000 | Closed |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$6K | -1,000 | Closed |
|
|
SWP
7
Stratos Wealth Partners
Beachwood,
Ohio
| – | +$407 | +76 | New |
|
TRPX Hedge Fund Activity: Q4 2017 in Review
5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Therapix Biosciences Ltd. (TRPX) for Q4 2017, worth a combined $77K — down 62% from $202K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TRPX and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $21.9K. The largest seller was Jane Street, exiting entirely with an estimated $77K sold.
- 5 institutional investors held Therapix Biosciences Ltd. (TRPX) as of Q4 2017, down from 6 in Q3 2017.
- Funds reported $77K of Therapix Biosciences Ltd. stock for Q4 2017, down 62% quarter-over-quarter.
- 2 funds opened new Therapix Biosciences Ltd. positions in Q4 2017 and 3 closed out, a net change of -1 holder.
- The largest Therapix Biosciences Ltd. buyer in Q4 2017 was Acadian Asset Management, an estimated $21.9K added.
- The largest Therapix Biosciences Ltd. seller in Q4 2017 was Jane Street, an estimated $77K sold.
Based on aggregated 13F filings for Q4 2017.